Report Detail
Global Prostaglandin I2 Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4742388 |
- 28 September, 2026 |
- Global |
- 98 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Prostaglandin I2 market size was valued at US$ 3001 million in 2025 and is forecast to a readjusted size of US$ 4537 million by 2032 with a CAGR of 6.2% during review period.
Prostaglandin I2 (PGI), or prostacyclin, is one of the prostanoids, a group of local hormones that are best known for their roles in mediating inflammation.
The prostaglandin I2 (PGI2) market is driven by its critical role as a potent vasodilator and inhibitor of platelet aggregation, making it an essential therapeutic option for various cardiovascular conditions. PGI2, also known as prostacyclin, is used to treat pulmonary arterial hypertension (PAH), preventing blood clot formation and improving blood flow in affected patients. The increasing prevalence of PAH and the growing awareness of its therapeutic benefits contribute to market growth. Moreover, advancements in pharmaceutical research and biotechnology have led to the development of new formulations and delivery methods for PGI2, further expanding its application in cardiovascular medicine. However, the market also faces challenges, including the high cost of PGI2 therapy, which may limit patient access and affordability. Additionally, the need for continuous infusion in some cases and potential side effects, such as bleeding complications, can pose obstacles for widespread adoption. To succeed in this market, manufacturers must focus on cost-effectiveness, patient-friendly administration methods, and conducting extensive clinical trials to establish the safety and efficacy of PGI2 therapies for various cardiovascular conditions, ensuring its continued use as a critical treatment option.
This report is a detailed and comprehensive analysis for global Prostaglandin I2 market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Prostaglandin I2 market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Prostaglandin I2 market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Prostaglandin I2 market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Prostaglandin I2 market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Prostaglandin I2
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Prostaglandin I2 market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include United Therapeutics, J & J, GSK, Teva, Toray, Tide Pharma, Bayer AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Prostaglandin I2 market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium
Market segment by Application
For Injection
For Oral
For Inhalation
Major players covered
United Therapeutics
J & J
GSK
Teva
Toray
Tide Pharma
Bayer AG
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prostaglandin I2 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Prostaglandin I2, with price, sales quantity, revenue, and global market share of Prostaglandin I2 from 2021 to 2026.
Chapter 3, the Prostaglandin I2 competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostaglandin I2 breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Prostaglandin I2 market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Prostaglandin I2.
Chapter 14 and 15, to describe Prostaglandin I2 sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Prostaglandin I2 Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Epoprostenol Sodium
- 1.3.3 Treprostinil
- 1.3.4 Iloprost
- 1.3.5 Beraprost Sodium
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Prostaglandin I2 Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 For Injection
- 1.4.3 For Oral
- 1.4.4 For Inhalation
- 1.5 Global Prostaglandin I2 Market Size & Forecast
- 1.5.1 Global Prostaglandin I2 Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Prostaglandin I2 Sales Quantity (2021-2032)
- 1.5.3 Global Prostaglandin I2 Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 United Therapeutics
- 2.1.1 United Therapeutics Details
- 2.1.2 United Therapeutics Major Business
- 2.1.3 United Therapeutics Prostaglandin I2 Product and Services
- 2.1.4 United Therapeutics Prostaglandin I2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 United Therapeutics Recent Developments/Updates
- 2.2 J & J
- 2.2.1 J & J Details
- 2.2.2 J & J Major Business
- 2.2.3 J & J Prostaglandin I2 Product and Services
- 2.2.4 J & J Prostaglandin I2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 J & J Recent Developments/Updates
- 2.3 GSK
- 2.3.1 GSK Details
- 2.3.2 GSK Major Business
- 2.3.3 GSK Prostaglandin I2 Product and Services
- 2.3.4 GSK Prostaglandin I2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 GSK Recent Developments/Updates
- 2.4 Teva
- 2.4.1 Teva Details
- 2.4.2 Teva Major Business
- 2.4.3 Teva Prostaglandin I2 Product and Services
- 2.4.4 Teva Prostaglandin I2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Teva Recent Developments/Updates
- 2.5 Toray
- 2.5.1 Toray Details
- 2.5.2 Toray Major Business
- 2.5.3 Toray Prostaglandin I2 Product and Services
- 2.5.4 Toray Prostaglandin I2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Toray Recent Developments/Updates
- 2.6 Tide Pharma
- 2.6.1 Tide Pharma Details
- 2.6.2 Tide Pharma Major Business
- 2.6.3 Tide Pharma Prostaglandin I2 Product and Services
- 2.6.4 Tide Pharma Prostaglandin I2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Tide Pharma Recent Developments/Updates
- 2.7 Bayer AG
- 2.7.1 Bayer AG Details
- 2.7.2 Bayer AG Major Business
- 2.7.3 Bayer AG Prostaglandin I2 Product and Services
- 2.7.4 Bayer AG Prostaglandin I2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Bayer AG Recent Developments/Updates
3 Competitive Environment: Prostaglandin I2 by Manufacturer
- 3.1 Global Prostaglandin I2 Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Prostaglandin I2 Revenue by Manufacturer (2021-2026)
- 3.3 Global Prostaglandin I2 Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Prostaglandin I2 by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Prostaglandin I2 Manufacturer Market Share in 2025
- 3.4.3 Top 6 Prostaglandin I2 Manufacturer Market Share in 2025
- 3.5 Prostaglandin I2 Market: Overall Company Footprint Analysis
- 3.5.1 Prostaglandin I2 Market: Region Footprint
- 3.5.2 Prostaglandin I2 Market: Company Product Type Footprint
- 3.5.3 Prostaglandin I2 Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Prostaglandin I2 Market Size by Region
- 4.1.1 Global Prostaglandin I2 Sales Quantity by Region (2021-2032)
- 4.1.2 Global Prostaglandin I2 Consumption Value by Region (2021-2032)
- 4.1.3 Global Prostaglandin I2 Average Price by Region (2021-2032)
- 4.2 North America Prostaglandin I2 Consumption Value (2021-2032)
- 4.3 Europe Prostaglandin I2 Consumption Value (2021-2032)
- 4.4 Asia-Pacific Prostaglandin I2 Consumption Value (2021-2032)
- 4.5 South America Prostaglandin I2 Consumption Value (2021-2032)
- 4.6 Middle East & Africa Prostaglandin I2 Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Prostaglandin I2 Sales Quantity by Type (2021-2032)
- 5.2 Global Prostaglandin I2 Consumption Value by Type (2021-2032)
- 5.3 Global Prostaglandin I2 Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Prostaglandin I2 Sales Quantity by Application (2021-2032)
- 6.2 Global Prostaglandin I2 Consumption Value by Application (2021-2032)
- 6.3 Global Prostaglandin I2 Average Price by Application (2021-2032)
7 North America
- 7.1 North America Prostaglandin I2 Sales Quantity by Type (2021-2032)
- 7.2 North America Prostaglandin I2 Sales Quantity by Application (2021-2032)
- 7.3 North America Prostaglandin I2 Market Size by Country
- 7.3.1 North America Prostaglandin I2 Sales Quantity by Country (2021-2032)
- 7.3.2 North America Prostaglandin I2 Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Prostaglandin I2 Sales Quantity by Type (2021-2032)
- 8.2 Europe Prostaglandin I2 Sales Quantity by Application (2021-2032)
- 8.3 Europe Prostaglandin I2 Market Size by Country
- 8.3.1 Europe Prostaglandin I2 Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Prostaglandin I2 Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Prostaglandin I2 Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Prostaglandin I2 Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Prostaglandin I2 Market Size by Region
- 9.3.1 Asia-Pacific Prostaglandin I2 Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Prostaglandin I2 Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Prostaglandin I2 Sales Quantity by Type (2021-2032)
- 10.2 South America Prostaglandin I2 Sales Quantity by Application (2021-2032)
- 10.3 South America Prostaglandin I2 Market Size by Country
- 10.3.1 South America Prostaglandin I2 Sales Quantity by Country (2021-2032)
- 10.3.2 South America Prostaglandin I2 Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Prostaglandin I2 Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Prostaglandin I2 Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Prostaglandin I2 Market Size by Country
- 11.3.1 Middle East & Africa Prostaglandin I2 Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Prostaglandin I2 Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Prostaglandin I2 Market Drivers
- 12.2 Prostaglandin I2 Market Restraints
- 12.3 Prostaglandin I2 Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Prostaglandin I2 and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Prostaglandin I2
- 13.3 Prostaglandin I2 Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Prostaglandin I2 Typical Distributors
- 14.3 Prostaglandin I2 Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Prostaglandin I2. Industry analysis & Market Report on Prostaglandin I2 is a syndicated market report, published as Global Prostaglandin I2 Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Prostaglandin I2 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
